Viewing StudyNCT03237416



Ignite Creation Date: 2024-05-06 @ 10:20 AM
Last Modification Date: 2024-10-26 @ 12:29 PM
Study NCT ID: NCT03237416
Status: COMPLETED
Last Update Posted: 2018-11-06
First Post: 2017-07-26

Brief Title: Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers
Sponsor: Bayer
Organization: Bayer

Organization Data

Organization: Bayer
Class: INDUSTRY
Study ID: 18860
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Bayer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Orion Corporation Orion Pharma INDUSTRY